Effect of Baduanjin on cardiopulmonary function in patients with stage 3-5 chronic kidney disease: a randomized controlled study

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•? Patients who met the diagnostic criteria for CKD and were CKD3-5 without dialysis.
•? Patients aged 18-75 years.
•? Patients with independent movement ability and able to complete baduanjin movement.
•? Informed consent.

•? If the following conditions need emergency treatment, the patient shall be excluded: HGB < 70g/L; Or carbon dioxide binding force < 13mmol/L; Or blood potassium > 5.5mmol/L.
•? Pregnant or lactating women.
•? Complicated with active malignant tumor, decompensated liver cirrhosis, gastrointestinal bleeding, hematopoietic system serious primary diseases; Patients with serious heart and lung diseases, such as acute myocardial infarction, unstable angina pectoris, acute pulmonary embolism or pulmonary infarction; Severe hypertension (systolic blood pressure =200mmHg, diastolic blood pressure =120mmHg) and difficult to control blood pressure; Severe vasculitis of lower extremities, deep venous thrombosis of lower extremities; Patients with muscle, bone, joint and other motor system lesions who cannot or should not exercise.
•? Patients with severe mental and cognitive disorders.
•? Patients are participating in other researches.

发起方

Guangdong Provincial Hospital of Chinese Medicine